In HF with mitral regurgitation, adding...

In HF with mitral regurgitation, adding transcatheter mitral valve repair to medical therapy improved renal outcomes at 2 y.

Abstract

SOURCE CITATION: Beohar N, Ailawadi G, Kotinkaduwa LN, et al. Impact of baseline renal dysfunction on cardiac outcomes and end-stage renal disease in heart failure patients with mitral regurgitation: the COAPT trial. Eur Heart J. 2022;43:1639-48. 35134897.

Authors

Damman K; Van Spall HGC

Journal

Annals of Internal Medicine, Vol. 175, No. 6,

Publisher

American College of Physicians

Publication Date

June 1, 2022

DOI

10.7326/j22-0037

ISSN

1056-8751

Associated Experts

Harriette Van Spall

Associate Professor, Faculty of Health Sciences

Visit profile

Labels